In Treatment of Severe bacterial infections Lizomed 600 I.V Infusion works by killing bacteria which can cause serious infections. It is used to treat many different types of bacterial infections such as infections of lungs (pneumonia), skin, and soft tissues. This medicine usually makes you feel better very quickly but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant.
It is unsafe to consume alcohol with Lizomed 600 I.V Infusion.
Lizomed 600 I.V Infusion may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Lizomed 600 I.V Infusion is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Lizomed 600 I.V Infusion may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Lizomed 600 I.V Infusion is safe to use in patients with kidney disease. No dose adjustment of Lizomed 600 I.V Infusion is recommended. However, talk to your doctor if you have any underlying kidney disease.
Lizomed 600 I.V Infusion should be used with caution in patients with severe liver disease. Dose adjustment of Lizomed 600 I.V Infusion may be needed. Please consult your doctor. Limited information is available on the use of Lizomed 600 I.V Infusion in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
If you miss a dose of Lizomed 600 I.V Infusion, consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Novartis India Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Macleods Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Kritikos Care || ₹14.5/tablet (25% cheaper)